The strong life sciences background of our attorneys has been the cornerstone of our well-rounded experience in pharmaceutical patent cases, including cases relating to small molecules, biological products, and pharmaceutical formulations. We have helped our clients achieve business results in cases brought under the Hatch-Waxman Act, often leading to favorable settlements before and during trial. In addition, we have employed creative licensing strategies and other measures to meet the business needs of our innovator clients.
